Cargando…

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria

BACKGROUND: Patients with primary hyperoxaluria (PH) often develop kidney stones and chronic kidney disease. Noninvasive urine markers reflective of active kidney injury could be useful to gauge the effectiveness of ongoing treatments. METHODS: A panel of biomarkers that reflect different nephron si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiangling, Bhutani, Gauri, Vaughan, Lisa E., Enders, Felicity T., Haskic, Zejfa, Milliner, Dawn, Lieske, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161151/ https://www.ncbi.nlm.nih.gov/pubmed/32293313 http://dx.doi.org/10.1186/s12882-020-01783-z

Ejemplares similares

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2020)

Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2021)

Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers
por: Lin, Zhijian, et al.
Publicado: (2022)

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023)

Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019)

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
por: Sas, David J., et al.
Publicado: (2021)

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
por: Milliner, Dawn S., et al.
Publicado: (2021)

Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition
por: Joshi, Sunil, et al.
Publicado: (2017)

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
por: Duan, Xiaolu, et al.
Publicado: (2018)

In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
por: Lubkowicz, David, et al.
Publicado: (2022)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage
por: Deng, Jiwang, et al.
Publicado: (2022)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
por: Kletzmayr, Anna, et al.
Publicado: (2020)

Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis
por: More-krong, Pimkanya, et al.
Publicado: (2020)

Secondary hyperoxaluria and urinary crystal casts after intestinal resection
por: Almeida, Jorge Reis, et al.
Publicado: (2009)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Evaluation of a high‐performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria
por: Shen, Ying, et al.
Publicado: (2021)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Concave Urinary Crystallines: Direct Evidence of Calcium Oxalate Crystals Dissolution by Citrate In Vivo
por: Shang, Yun-Feng, et al.
Publicado: (2013)

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
por: Metry, Elisabeth L, et al.
Publicado: (2023)

Fasting Urinary Calcium‐to‐Creatinine and Oxalate‐to‐Creatinine Ratios in Dogs with Calcium Oxalate Urolithiasis and Breed‐Matched Controls
por: Furrow, E., et al.
Publicado: (2015)

Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022)

Calcium Oxalate Crystals in Eucalypt Ectomycorrhizae: Morphochemical Characterization
por: Pylro, Victor Satler, et al.
Publicado: (2013)

In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization
por: Chaudhary, A., et al.
Publicado: (2010)

Prevention of Calcium Nephrolithiasis: The Influence of Diuresis on Calcium Oxalate Crystallization in Urine
por: Baumann, Johannes M., et al.
Publicado: (2019)

Reinjury risk of nano-calcium oxalate monohydrate and calcium oxalate dihydrate crystals on injured renal epithelial cells: aggravation of crystal adhesion and aggregation
por: Gan, Qiong-Zhi, et al.
Publicado: (2016)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages
por: Dominguez-Gutierrez, Paul R., et al.
Publicado: (2018)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Plasma oxalate: comparison of methodologies
por: Stokes, Felicity, et al.
Publicado: (2020)

Application of multivariate joint modeling of longitudinal biomarkers and time-to-event data to a rare kidney stone cohort
por: Vaughan, Lisa E., et al.
Publicado: (2022)

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
por: Dutta, Chaitali, et al.
Publicado: (2016)

Calcium oxalate crystals and oxalate induce an epithelial-to-mesenchymal transition in the proximal tubular epithelial cells: Contribution to oxalate kidney injury
por: Convento, Marcia Bastos, et al.
Publicado: (2017)

Primary Hyperoxaluria Involving the Liver With Crystal Deposits
por: Bansal, Nalini, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0t4utiaphju9aaeqdpmt15k8d9